Transmucosal Drug Delivery Market Report

Europe Transmucosal Drug Delivery Market Size, Status and Forecast 2014-2026

  • POSTDATE：Nov 13, 2019
  • PAGES：166
  • REPORT CODE：GMM377613
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Transmucosal Drug Delivery market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 7.4% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Transmucosal Drug Delivery Market Segmentations:

    By Player:

    • Zosano Pharma

    • MedPharm LTD.

    • Acrux Limited

    • Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG).

    • Tapemark

    • Pantec Biosolutions AG.

    • 3M Pharmaceuticals

    • ALZA Corporation

    • TEVA Pharmaceutical Industries Ltd

    • Nemaura Pharma Ltd

    • Tesa Labtec GmbH.

    • Noven Pharmaceuticals, Inc.

    • Aveva Drug Delivery Systems

    • Corium International, Inc

    • Antares Pharma, Inc

    • Nitto Denko Corporation

    • Inovio Pharmaceuticals, Inc

    • Mylan, Inc

    • Apricus BioSciences, Inc

    • Generex Biotechnology Corporation

    • DURECT Corporation

    By Type:

    • Passive Transdermal Drug Delivery

    • Active Transdermal Drug Delivery

    By End-User:

    • Clinics

    • Hospitals

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Transmucosal Drug Delivery Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Transmucosal Drug Delivery Market Size and Growth Rate of Passive Transdermal Drug Delivery from 2014 to 2026

    • 1.3.2 Europe Transmucosal Drug Delivery Market Size and Growth Rate of Active Transdermal Drug Delivery from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Transmucosal Drug Delivery Market Size and Growth Rate of Clinics from 2014 to 2026

    • 1.4.2 Europe Transmucosal Drug Delivery Market Size and Growth Rate of Hospitals from 2014 to 2026

    • 1.4.3 Europe Transmucosal Drug Delivery Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Transmucosal Drug Delivery Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Transmucosal Drug Delivery by Major Types

      • 3.4.1 Market Size and Growth Rate of Passive Transdermal Drug Delivery

      • 3.4.2 Market Size and Growth Rate of Active Transdermal Drug Delivery

    4 Segmentation of Transmucosal Drug Delivery Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Transmucosal Drug Delivery by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Transmucosal Drug Delivery for Clinics

      • 4.4.2 Market Size and Growth Rate of Transmucosal Drug Delivery for Hospitals

      • 4.4.3 Market Size and Growth Rate of Transmucosal Drug Delivery for Others

    5 Market Analysis by Major Regions

    • 5.1 Europe Transmucosal Drug Delivery Production Analysis by Top Regions

    • 5.2 Europe Transmucosal Drug Delivery Consumption Analysis by Top Regions

    • 5.3 Europe Transmucosal Drug Delivery Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Transmucosal Drug Delivery Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Transmucosal Drug Delivery Production, Import, Consumption and Export Analysis

      • 5.3.3 France Transmucosal Drug Delivery Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Transmucosal Drug Delivery Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Transmucosal Drug Delivery Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Transmucosal Drug Delivery Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Transmucosal Drug Delivery Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Transmucosal Drug Delivery Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Transmucosal Drug Delivery Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transmucosal Drug Delivery Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Transmucosal Drug Delivery Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Transmucosal Drug Delivery Production, Import, Consumption and Export Analysis

    6 Product Circulation of Transmucosal Drug Delivery Market among Top Countries

    • 6.1 Top 5 Export Countries in Transmucosal Drug Delivery Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Transmucosal Drug Delivery Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Transmucosal Drug Delivery Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Transmucosal Drug Delivery Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Transmucosal Drug Delivery Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Transmucosal Drug Delivery Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Transmucosal Drug Delivery Landscape Analysis

    • 7.1 Germany Transmucosal Drug Delivery Landscape Analysis by Major Types

    • 7.2 Germany Transmucosal Drug Delivery Landscape Analysis by Major End-Users

    8. UK Transmucosal Drug Delivery Landscape Analysis

    • 8.1 UK Transmucosal Drug Delivery Landscape Analysis by Major Types

    • 8.2 UK Transmucosal Drug Delivery Landscape Analysis by Major End-Users

    9. France Transmucosal Drug Delivery Landscape Analysis

    • 9.1 France Transmucosal Drug Delivery Landscape Analysis by Major Types

    • 9.2 France Transmucosal Drug Delivery Landscape Analysis by Major End-Users

    10. Italy Transmucosal Drug Delivery Landscape Analysis

    • 10.1 Italy Transmucosal Drug Delivery Landscape Analysis by Major Types

    • 10.2 Italy Transmucosal Drug Delivery Landscape Analysis by Major End-Users

    11. Spain Transmucosal Drug Delivery Landscape Analysis

    • 11.1 Spain Transmucosal Drug Delivery Landscape Analysis by Major Types

    • 11.2 Spain Transmucosal Drug Delivery Landscape Analysis by Major End-Users

    12. Poland Transmucosal Drug Delivery Landscape Analysis

    • 12.1 Poland Transmucosal Drug Delivery Landscape Analysis by Major Types

    • 12.2 Poland Transmucosal Drug Delivery Landscape Analysis by Major End-Users

    13. Russia Transmucosal Drug Delivery Landscape Analysis

    • 13.1 Russia Transmucosal Drug Delivery Landscape Analysis by Major Types

    • 13.2 Russia Transmucosal Drug Delivery Landscape Analysis by Major End-Users

    14. Switzerland Transmucosal Drug Delivery Landscape Analysis

    • 14.1 Switzerland Transmucosal Drug Delivery Landscape Analysis by Major Types

    • 14.2 Switzerland Transmucosal Drug Delivery Landscape Analysis by Major End-Users

    15. Turkey Transmucosal Drug Delivery Landscape Analysis

    • 15.1 Turkey Transmucosal Drug Delivery Landscape Analysis by Major Types

    • 15.2 Turkey Transmucosal Drug Delivery Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transmucosal Drug Delivery Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transmucosal Drug Delivery Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transmucosal Drug Delivery Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transmucosal Drug Delivery Landscape Analysis by Top Countries

      • 16.3.1 Denmark Transmucosal Drug Delivery Market Volume and Growth Rate

      • 16.3.2 Finland Transmucosal Drug Delivery Market Volume and Growth Rate

      • 16.3.3 Norway Transmucosal Drug Delivery Market Volume and Growth Rate

      • 16.3.4 Sweden Transmucosal Drug Delivery Market Volume and Growth Rate

      • 16.3.6 Iceland Transmucosal Drug Delivery Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Transmucosal Drug Delivery Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Transmucosal Drug Delivery Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Transmucosal Drug Delivery Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Transmucosal Drug Delivery Landscape Analysis by Top Countries

      • 17.3.1 Belgium Transmucosal Drug Delivery Market Volume and Growth Rate

      • 17.3.2 Netherlands Transmucosal Drug Delivery Market Volume and Growth Rate

      • 17.3.3 Luxembourg Transmucosal Drug Delivery Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Transmucosal Drug Delivery Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Transmucosal Drug Delivery Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Transmucosal Drug Delivery Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Transmucosal Drug Delivery Landscape Analysis by Top Countries

      • 18.3.1 Estonia Transmucosal Drug Delivery Market Volume and Growth Rate

      • 18.3.2 Latvia Transmucosal Drug Delivery Market Volume and Growth Rate

      • 18.3.3 Lithuania Transmucosal Drug Delivery Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Zosano Pharma

      • 19.1.1 Zosano Pharma Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 MedPharm LTD.

      • 19.2.1 MedPharm LTD. Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Acrux Limited

      • 19.3.1 Acrux Limited Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG).

      • 19.4.1 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG). Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Tapemark

      • 19.5.1 Tapemark Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Pantec Biosolutions AG.

      • 19.6.1 Pantec Biosolutions AG. Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 3M Pharmaceuticals

      • 19.7.1 3M Pharmaceuticals Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 ALZA Corporation

      • 19.8.1 ALZA Corporation Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 TEVA Pharmaceutical Industries Ltd

      • 19.9.1 TEVA Pharmaceutical Industries Ltd Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Nemaura Pharma Ltd

      • 19.10.1 Nemaura Pharma Ltd Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Tesa Labtec GmbH.

      • 19.11.1 Tesa Labtec GmbH. Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Noven Pharmaceuticals, Inc.

      • 19.12.1 Noven Pharmaceuticals, Inc. Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Aveva Drug Delivery Systems

      • 19.13.1 Aveva Drug Delivery Systems Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Corium International, Inc

      • 19.14.1 Corium International, Inc Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Antares Pharma, Inc

      • 19.15.1 Antares Pharma, Inc Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Nitto Denko Corporation

      • 19.16.1 Nitto Denko Corporation Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Inovio Pharmaceuticals, Inc

      • 19.17.1 Inovio Pharmaceuticals, Inc Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 Mylan, Inc

      • 19.18.1 Mylan, Inc Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 Apricus BioSciences, Inc

      • 19.19.1 Apricus BioSciences, Inc Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 Generex Biotechnology Corporation

      • 19.20.1 Generex Biotechnology Corporation Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    • 19.21 DURECT Corporation

      • 19.21.1 DURECT Corporation Company Profile and Development Status

      • 19.21.2 Market Performance

      • 19.21.3 Product and Service Introduction

    The List of Tables and Figures (Totals 102 Figures and 142 Tables)

    • Figure Product Picture

    • Figure Europe Transmucosal Drug Delivery Market Size and Growth Rate of Passive Transdermal Drug Delivery from 2014 to 2026

    • Figure Europe Transmucosal Drug Delivery Market Size and Growth Rate of Active Transdermal Drug Delivery from 2014 to 2026

    • Figure Europe Transmucosal Drug Delivery Market Size and Growth Rate of Clinics from 2014 to 2026

    • Figure Europe Transmucosal Drug Delivery Market Size and Growth Rate of Hospitals from 2014 to 2026

    • Figure Europe Transmucosal Drug Delivery Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

    • Figure UK Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

    • Figure France Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Transmucosal Drug Delivery Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Transmucosal Drug Delivery Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Transmucosal Drug Delivery

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Transmucosal Drug Delivery by Different Types from 2014 to 2026

    • Table Consumption Share of Transmucosal Drug Delivery by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Passive Transdermal Drug Delivery

    • Figure Market Size and Growth Rate of Active Transdermal Drug Delivery

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Transmucosal Drug Delivery by Different End-Users from 2014 to 2026

    • Table Consumption Share of Transmucosal Drug Delivery by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Clinics

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Others

    • Table Europe Transmucosal Drug Delivery Production by Major Regions

    • Table Europe Transmucosal Drug Delivery Production Share by Major Regions

    • Figure Europe Transmucosal Drug Delivery Production Share by Major Countries and Regions in 2014

    • Table Europe Transmucosal Drug Delivery Consumption by Major Regions

    • Table Europe Transmucosal Drug Delivery Consumption Share by Major Regions

    • Table Germany Transmucosal Drug Delivery Production, Import, Consumption and Export Analysis

    • Table UK Transmucosal Drug Delivery Production, Import, Consumption and Export Analysis

    • Table France Transmucosal Drug Delivery Production, Import, Consumption and Export Analysis

    • Table Italy Transmucosal Drug Delivery Production, Import, Consumption and Export Analysis

    • Table Spain Transmucosal Drug Delivery Production, Import, Consumption and Export Analysis

    • Table Poland Transmucosal Drug Delivery Production, Import, Consumption and Export Analysis

    • Table Russia Transmucosal Drug Delivery Production, Import, Consumption and Export Analysis

    • Table Switzerland Transmucosal Drug Delivery Production, Import, Consumption and Export Analysis

    • Table Turkey Transmucosal Drug Delivery Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transmucosal Drug Delivery Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Transmucosal Drug Delivery Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Transmucosal Drug Delivery Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Transmucosal Drug Delivery Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Transmucosal Drug Delivery Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Transmucosal Drug Delivery Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Transmucosal Drug Delivery Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Transmucosal Drug Delivery Consumption by Types from 2014 to 2026

    • Table Germany Transmucosal Drug Delivery Consumption Share by Types from 2014 to 2026

    • Table Germany Transmucosal Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Germany Transmucosal Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Table UK Transmucosal Drug Delivery Consumption by Types from 2014 to 2026

    • Table UK Transmucosal Drug Delivery Consumption Share by Types from 2014 to 2026

    • Table UK Transmucosal Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table UK Transmucosal Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Table France Transmucosal Drug Delivery Consumption by Types from 2014 to 2026

    • Table France Transmucosal Drug Delivery Consumption Share by Types from 2014 to 2026

    • Table France Transmucosal Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table France Transmucosal Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Table Italy Transmucosal Drug Delivery Consumption by Types from 2014 to 2026

    • Table Italy Transmucosal Drug Delivery Consumption Share by Types from 2014 to 2026

    • Table Italy Transmucosal Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Italy Transmucosal Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Table Spain Transmucosal Drug Delivery Consumption by Types from 2014 to 2026

    • Table Spain Transmucosal Drug Delivery Consumption Share by Types from 2014 to 2026

    • Table Spain Transmucosal Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Spain Transmucosal Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Table Poland Transmucosal Drug Delivery Consumption by Types from 2014 to 2026

    • Table Poland Transmucosal Drug Delivery Consumption Share by Types from 2014 to 2026

    • Table Poland Transmucosal Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Poland Transmucosal Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Table Russia Transmucosal Drug Delivery Consumption by Types from 2014 to 2026

    • Table Russia Transmucosal Drug Delivery Consumption Share by Types from 2014 to 2026

    • Table Russia Transmucosal Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Russia Transmucosal Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Transmucosal Drug Delivery Consumption by Types from 2014 to 2026

    • Table Switzerland Transmucosal Drug Delivery Consumption Share by Types from 2014 to 2026

    • Table Switzerland Transmucosal Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Switzerland Transmucosal Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Transmucosal Drug Delivery Consumption by Types from 2014 to 2026

    • Table Turkey Transmucosal Drug Delivery Consumption Share by Types from 2014 to 2026

    • Table Turkey Transmucosal Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Turkey Transmucosal Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transmucosal Drug Delivery Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transmucosal Drug Delivery Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transmucosal Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transmucosal Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transmucosal Drug Delivery Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transmucosal Drug Delivery Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Transmucosal Drug Delivery Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Transmucosal Drug Delivery Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Transmucosal Drug Delivery Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Transmucosal Drug Delivery Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Transmucosal Drug Delivery Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Transmucosal Drug Delivery Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Transmucosal Drug Delivery Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Transmucosal Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Transmucosal Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Transmucosal Drug Delivery Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Transmucosal Drug Delivery Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Transmucosal Drug Delivery Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Transmucosal Drug Delivery Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Transmucosal Drug Delivery Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Transmucosal Drug Delivery Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Transmucosal Drug Delivery Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Transmucosal Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Transmucosal Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Transmucosal Drug Delivery Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Transmucosal Drug Delivery Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Transmucosal Drug Delivery Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Transmucosal Drug Delivery Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Transmucosal Drug Delivery Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Zosano Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zosano Pharma

    • Figure Sales and Growth Rate Analysis of Zosano Pharma

    • Figure Revenue and Market Share Analysis of Zosano Pharma

    • Table Product and Service Introduction of Zosano Pharma

    • Table Company Profile and Development Status of MedPharm LTD.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MedPharm LTD.

    • Figure Sales and Growth Rate Analysis of MedPharm LTD.

    • Figure Revenue and Market Share Analysis of MedPharm LTD.

    • Table Product and Service Introduction of MedPharm LTD.

    • Table Company Profile and Development Status of Acrux Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Acrux Limited

    • Figure Sales and Growth Rate Analysis of Acrux Limited

    • Figure Revenue and Market Share Analysis of Acrux Limited

    • Table Product and Service Introduction of Acrux Limited

    • Table Company Profile and Development Status of Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG).

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG).

    • Figure Sales and Growth Rate Analysis of Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG).

    • Figure Revenue and Market Share Analysis of Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG).

    • Table Product and Service Introduction of Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG).

    • Table Company Profile and Development Status of Tapemark

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tapemark

    • Figure Sales and Growth Rate Analysis of Tapemark

    • Figure Revenue and Market Share Analysis of Tapemark

    • Table Product and Service Introduction of Tapemark

    • Table Company Profile and Development Status of Pantec Biosolutions AG.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pantec Biosolutions AG.

    • Figure Sales and Growth Rate Analysis of Pantec Biosolutions AG.

    • Figure Revenue and Market Share Analysis of Pantec Biosolutions AG.

    • Table Product and Service Introduction of Pantec Biosolutions AG.

    • Table Company Profile and Development Status of 3M Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of 3M Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of 3M Pharmaceuticals

    • Figure Revenue and Market Share Analysis of 3M Pharmaceuticals

    • Table Product and Service Introduction of 3M Pharmaceuticals

    • Table Company Profile and Development Status of ALZA Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ALZA Corporation

    • Figure Sales and Growth Rate Analysis of ALZA Corporation

    • Figure Revenue and Market Share Analysis of ALZA Corporation

    • Table Product and Service Introduction of ALZA Corporation

    • Table Company Profile and Development Status of TEVA Pharmaceutical Industries Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of TEVA Pharmaceutical Industries Ltd

    • Figure Sales and Growth Rate Analysis of TEVA Pharmaceutical Industries Ltd

    • Figure Revenue and Market Share Analysis of TEVA Pharmaceutical Industries Ltd

    • Table Product and Service Introduction of TEVA Pharmaceutical Industries Ltd

    • Table Company Profile and Development Status of Nemaura Pharma Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nemaura Pharma Ltd

    • Figure Sales and Growth Rate Analysis of Nemaura Pharma Ltd

    • Figure Revenue and Market Share Analysis of Nemaura Pharma Ltd

    • Table Product and Service Introduction of Nemaura Pharma Ltd

    • Table Company Profile and Development Status of Tesa Labtec GmbH.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tesa Labtec GmbH.

    • Figure Sales and Growth Rate Analysis of Tesa Labtec GmbH.

    • Figure Revenue and Market Share Analysis of Tesa Labtec GmbH.

    • Table Product and Service Introduction of Tesa Labtec GmbH.

    • Table Company Profile and Development Status of Noven Pharmaceuticals, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Noven Pharmaceuticals, Inc.

    • Figure Sales and Growth Rate Analysis of Noven Pharmaceuticals, Inc.

    • Figure Revenue and Market Share Analysis of Noven Pharmaceuticals, Inc.

    • Table Product and Service Introduction of Noven Pharmaceuticals, Inc.

    • Table Company Profile and Development Status of Aveva Drug Delivery Systems

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aveva Drug Delivery Systems

    • Figure Sales and Growth Rate Analysis of Aveva Drug Delivery Systems

    • Figure Revenue and Market Share Analysis of Aveva Drug Delivery Systems

    • Table Product and Service Introduction of Aveva Drug Delivery Systems

    • Table Company Profile and Development Status of Corium International, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Corium International, Inc

    • Figure Sales and Growth Rate Analysis of Corium International, Inc

    • Figure Revenue and Market Share Analysis of Corium International, Inc

    • Table Product and Service Introduction of Corium International, Inc

    • Table Company Profile and Development Status of Antares Pharma, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Antares Pharma, Inc

    • Figure Sales and Growth Rate Analysis of Antares Pharma, Inc

    • Figure Revenue and Market Share Analysis of Antares Pharma, Inc

    • Table Product and Service Introduction of Antares Pharma, Inc

    • Table Company Profile and Development Status of Nitto Denko Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nitto Denko Corporation

    • Figure Sales and Growth Rate Analysis of Nitto Denko Corporation

    • Figure Revenue and Market Share Analysis of Nitto Denko Corporation

    • Table Product and Service Introduction of Nitto Denko Corporation

    • Table Company Profile and Development Status of Inovio Pharmaceuticals, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Inovio Pharmaceuticals, Inc

    • Figure Sales and Growth Rate Analysis of Inovio Pharmaceuticals, Inc

    • Figure Revenue and Market Share Analysis of Inovio Pharmaceuticals, Inc

    • Table Product and Service Introduction of Inovio Pharmaceuticals, Inc

    • Table Company Profile and Development Status of Mylan, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan, Inc

    • Figure Sales and Growth Rate Analysis of Mylan, Inc

    • Figure Revenue and Market Share Analysis of Mylan, Inc

    • Table Product and Service Introduction of Mylan, Inc

    • Table Company Profile and Development Status of Apricus BioSciences, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Apricus BioSciences, Inc

    • Figure Sales and Growth Rate Analysis of Apricus BioSciences, Inc

    • Figure Revenue and Market Share Analysis of Apricus BioSciences, Inc

    • Table Product and Service Introduction of Apricus BioSciences, Inc

    • Table Company Profile and Development Status of Generex Biotechnology Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Generex Biotechnology Corporation

    • Figure Sales and Growth Rate Analysis of Generex Biotechnology Corporation

    • Figure Revenue and Market Share Analysis of Generex Biotechnology Corporation

    • Table Product and Service Introduction of Generex Biotechnology Corporation

    • Table Company Profile and Development Status of DURECT Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of DURECT Corporation

    • Figure Sales and Growth Rate Analysis of DURECT Corporation

    • Figure Revenue and Market Share Analysis of DURECT Corporation

    • Table Product and Service Introduction of DURECT Corporation

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US